Libertatis Ergo Holding

Libertatis Ergo Holding serves as the dedicated investment arm of Leiden University, focusing exclusively on science-based startups emerging from the university's research ecosystem. Established to bridge the gap between academic innovation and commercial viability, the fund strategically deploys capital to transform promising scientific breakthroughs into market-ready ventures. With a deep understanding of both academic research processes and business development requirements, Libertatis Ergo provides not just financial backing but also crucial guidance through the complex journey from laboratory to marketplace. Their investment approach is characterized by patience and scientific rigor, recognizing that deep-tech innovations often require longer development timelines.

The fund maintains a diversified portfolio spanning multiple scientific disciplines, including life sciences, biotechnology, quantum computing, sustainable technologies, and medical innovations. By leveraging Leiden University's centuries-old research excellence and extensive scientific network, Libertatis Ergo identifies opportunities with significant intellectual property advantages and disruptive potential. Their investment strategy typically focuses on pre-seed and seed-stage companies, with follow-on investments available for portfolio companies demonstrating exceptional progress. Portfolio companies benefit from access to Leiden's world-class research facilities, creating a symbiotic relationship that accelerates technological development while maintaining scientific integrity.

Beyond capital injection, Libertatis Ergo offers a comprehensive support system designed specifically for science-based ventures. This includes connections to specialized mentors, industry partners, regulatory experts, and additional funding sources within their extensive network. The fund's investment committee combines academic luminaries with seasoned venture capitalists, ensuring decisions are based on both scientific merit and commercial potential. This dual-perspective approach has established Libertatis Ergo as a respected player in the European deep-tech investment landscape. Their hands-on involvement helps academic founders navigate the challenging transition to entrepreneurship, addressing common pitfalls that often derail science-based startups.

With a geographic focus primarily on innovations emerging from the Netherlands and broader European research institutions, Libertatis Ergo has built strategic partnerships with other university-affiliated funds and specialized venture capital firms. This collaborative approach enables portfolio companies to access international markets and secure subsequent funding rounds more effectively. The fund measures success not only through financial returns but also through broader impact metrics including patents filed, jobs created, and societal benefits delivered. Libertatis Ergo's long-term vision centers on establishing Leiden University as a premier hub for commercializing scientific breakthroughs, contributing to both economic development and solutions to pressing global challenges through responsible innovation.